Daily Dispatch

The 'Dispatched' Podcast

News EN ↓ 209 episodes

BioPharmaDispatch - discussing the issues impacting the Australian biopharmaceutical and life sciences sectors with Paul Cross and Felicity McNeill.

Be sure to visit the podcast's website and support the creator: bpd.captivate.fm

Author

Daily Dispatch

Category

News

Podcast website

bpd.captivate.fm

Latest episode

Nov 13, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

The 'Week in Review' - 2 December 02.12.2022

This week's Pfizer 'Invites' event featured an interesting expert discussion on pandemic preparedness. We answer lots of listener questions on that issue and other topics, including why the medical device and frankly all stakeholders should push for close parliamentary scrutiny of three pieces of new legislation.

The 'Week in Review' - 25 November 25.11.2022

It is the anniversary of the report of the parliamentary inquiry into approval processes for new medicines and medical technologies and still no government response, but we do have the outcome of the review of the base-case discount rate. They both say so much about the current state of policy-making in Australia. We also answer audience questions on top-down patient consultation and whether every...

The 'Week in Review' - 18 November 18.11.2022

We discuss the response to the reports of a problematic culture at the heart of HTA decision-making, the need for greater alignment across the pharmaceutical, medical device and diagnostic sectors, and answer your questions about statutory price reductions and patient 'consultation' processes.

The 'Week in Review' - 11 November 11.11.2022

We are joined by Better Access Australia chair Felicity McNeill to respond to questions submitted by listeners and give a shout-out to one patient advocate who in one social media post articulated a clear critique of PBS decision-making. We also discuss why more HTA is not a solution to delays in funded access.

The 'Week in Review' - 4 November 03.11.2022

We discuss Monday's Post-Budget Summit and a discussion that revealed an opportunity for a refreshed approach to political engagement. Medicines Australia has a new set of directors who will need to deal with a long-standing challenge and a raft of issues with its new agreement with the federal government. Next week is Senate Estimates and we would like to hear from you.

The 'Week in Review' - 28 October 28.10.2022

A busy week with the Albanese government delivering its first Budget. The reduction in the general PBS co-payment was a centrepiece. The Senate backed the enabling legislation with a very subtle but powerful amendment that proves the importance of detail in advocacy. The amendment and how it was achieved is an important lesson for stakeholders in how they approach the much-anticipated HTA review.

The 'Dispatched' podcast - Budget week review 23.10.2022

We review this Budget week, how it has changed over the years and what else might be revealed by Treasurer Jim Chalmers. Are some Senators pushing to amend the proposed PBS co-payment reduction? How is it a good idea to reduce patient participation in post-market reviews and why the discussion on health technology assessment is the policy equivalent of 'quick sand'?

The 'Week in Review' - 21 October 21.10.2022

A new review of Australia's pandemic response confirms what we already knew about the failures in vaccine procurement and distribution, the new post-market review process removes patient consultation, it could be an interesting few weeks in the Senate for the PBS, the final days for companies to provide additional information in support of their case for relief from  April's 'catch-...

The 'Week in Review' - 14 October 14.10.2022

The 'Week in Review' includes a  special guest who discusses the 'indicative outcomes' communicated to companies seeking relief from next April's 'catch-up' price cuts, the implications for public health, what they say about a system 'under strain' and why change is urgently needed. There is also a discussion about the recommended lung cancer screening...

The 'Week in Review' - 7 October 07.10.2022

The review discusses 'what now' after the industry has presented its evidence on the disputed implementation of the PBS pricing framework, the challenge of timing, the potential implications of the multinational tax review, and planning for the BPD Post-Budget Summit.

Introducing the first 'Week in Review' episode of 'The Dispatched Podcast' 30.09.2022

The first 'Week in Review' episode of 'The Dispatched Podcast' discusses the ongoing dispute over the implementation of the new PBS pricing framework, the 'Halton review' of Australia's COVID-19 vaccine and treatment procurement planning, and the significant implications of the new national anti-corruption commission.

Farewelling a legend and understanding the reality of policy 19.09.2022

The latest edition of 'The Dispatched' podcast pays tribute to the late Will Delaat AM and discusses the importance of detail, substance and long-term thinking when it comes to policy.

The challenge is to assess changes assuming the worst possible outcome 02.08.2022

This episode focuses on the contentious 'catch-up' price reductions, the wording of industry agreements, the clever but consistent policy approach, the real risk of other 'surprises' and the discomfort of having to defend federal government officials.

Insight Strategy's Jody Fassina on the 47th parliament 24.07.2022

Jody Fassina discusses the composition of the new parliament and its implications for politics and policy, the fiscal challenges confronting the new government and how stakeholders should engage the new ministry.

The 'disturbing' case against a major Labor election commitment 19.06.2022

The latest edition of The 'Dispatched' Podcast discusses some of the frankly disturbing arguments against the implementation of a key Labor election commitment. 

The 'mechanics' of political change 21.05.2022

The Dispatched podcast discusses the mechanics of ministerial change. What happens? What are the challenges? The reality and how stakeholders should approach what is a significant change?

We need to know the 'why' before worrying about the 'how' 08.05.2022

The latest episode of 'The Dispatched Podcast' discusses Labor's call for the Coalition to match its commitment to a national takeover of newborn screening and why the health technology assessment review cannot start until the National Medicines Policy review is restarted and finished.

Newborn screening - the how, the what and the why? 06.04.2022

In this week's episode, the 'Dispatched Podcast' discusses Labor's commitment to a national takeover of newborn screening. Why is there a need for change? What does the change mean for Australian families and how did we ever get into this situation?

Budget 2022-23 and the lowering of expectations 28.03.2022

What is in Budget 2022-23 and what is not. The lack of action on medicines affordability, funding for pre-symptomatic treatments but not screening for the disease and how the PBS forecast is money out but uncertain about money back in.

Political condescension, the biggest reform in 30 years and next week's Budget 21.03.2022

The political and policy condescension of patients needs to stop. The health technology assessment review has been called one of the biggest health reforms in the past 30 years. What is the competition and what will it need to achieve to sit alongside these major reforms? The federal government is about to deliver its pre-election 2022-23 Budget. What has changed and what to expect? What was it li...

'It should be about affordability for patients, not the government' 05.02.2022

The co-founder and chair of Better Access Australia, Felicity McNeill PSM, discusses the organisation's call for a delay in the National Medicines Policy review following the recent release of the revised document. She also says the upcoming 2022-23 Budget and federal election is an opportunity for political leaders to consider the rising challenge of medicines affordability.

Nicole Cooper - 'I am a patient, not a consumer' 19.12.2021

BioPharmaDispatch is finishing 2021 with a podcast with Nicole Cooper of Convalis Consulting. Ms Cooper is approaching the fifth anniversary of her diagnosis with an advanced form of cancer. She talks ahead of her latest round of treatment and urges decision-makers to do better on understanding and supporting the experience and journey of individual patients.

Novartis' Richard Tew - 'Collaboration and intent but the system needs a design change' 18.12.2021

The general manager and country president of Novartis Pharmaceuticals Australia and NZ, Richard Tew, says there are actions the government can take now to enhance the eco-system for biopharmaceutical innovation. Mr Tew says decision-making is characterised by collaboration and positive intent but it is just not designed for the new technologies already emerging from company pipelines.

PAIG - J&J's Fiona Sheppard and Pfizer's Lee Davelaar 15.12.2021

The co-chairs of the Pharma Australia Inclusion Group, J&J's Fiona Sheppard and Pfizer's Lee Davelaar, discuss their personal journeys on diversity and inclusion, the group's activities in 2021, including how it supports companies, and plans for next year.

Budget update and looking ahead to the federal election with Insight Strategy's Jody Fassina 15.12.2021

Jody Fassina of Insight Strategy shares his thoughts on today's Budget update and the upcoming federal election. He discusses the implications for stakeholders, including the pharmaceutical sector, the new politics of health and even makes an early prediction on the result.

Listen to the The 'Dispatched' Podcast podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.